HDAC2 and chronic obstructive pulmonary disease: Patients with chronic obstructive pulmonary disease (COPD) who exhibit predominant neutrophilia and downregulation of histone deacetylase (HDAC2) demonstrate limited responsiveness to pharmacological steroid therapy.